GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioRestorative Therapies Inc (NAS:BRTX) » Definitions » Cyclically Adjusted PB Ratio

BioRestorative Therapies (BioRestorative Therapies) Cyclically Adjusted PB Ratio : (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is BioRestorative Therapies Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioRestorative Therapies Cyclically Adjusted PB Ratio Historical Data

The historical data trend for BioRestorative Therapies's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioRestorative Therapies Cyclically Adjusted PB Ratio Chart

BioRestorative Therapies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioRestorative Therapies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioRestorative Therapies's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, BioRestorative Therapies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioRestorative Therapies's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioRestorative Therapies's Cyclically Adjusted PB Ratio falls into.



BioRestorative Therapies Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioRestorative Therapies's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, BioRestorative Therapies's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.45/129.4194*129.4194
=2.450

Current CPI (Dec. 2023) = 129.4194.

BioRestorative Therapies Quarterly Data

Book Value per Share CPI Adj_Book
201403 -25,862.963 99.695 -33,574.261
201406 -23,061.290 100.560 -29,679.725
201409 -16,558.974 100.428 -21,339.236
201412 -16,400.000 99.070 -21,424.090
201503 -16,076.087 99.621 -20,884.707
201506 -4,115.714 100.684 -5,290.352
201509 -5,318.310 100.392 -6,856.083
201512 -4,708.434 99.792 -6,106.304
201603 -3,613.265 100.470 -4,654.372
201606 -3,850.962 101.688 -4,901.156
201609 -4,027.928 101.861 -5,117.680
201612 -4,273.504 101.863 -5,429.606
201703 -3,550.376 102.862 -4,467.020
201706 -4,171.533 103.349 -5,223.822
201709 -4,778.571 104.136 -5,938.793
201712 -4,468.627 104.011 -5,560.243
201803 -4,746.914 105.290 -5,834.796
201806 -5,839.053 106.317 -7,107.877
201809 -4,100.000 106.507 -4,982.030
201812 -2,949.147 105.998 -3,600.796
201903 -2,079.620 107.251 -2,509.482
201906 -1,806.465 108.070 -2,163.345
201909 -2,095.953 108.329 -2,504.001
201912 -656.526 108.420 -783.685
202003 -43.987 108.902 -52.274
202006 -36.224 108.767 -43.102
202009 -37.859 109.815 -44.618
202012 -1.860 109.897 -2.190
202103 -3.393 111.754 -3.929
202106 -4.551 114.631 -5.138
202109 -5.594 115.734 -6.255
202112 6.131 117.630 6.746
202203 5.546 121.301 5.917
202206 5.097 125.017 5.276
202209 4.659 125.227 4.815
202212 4.301 125.222 4.445
202303 3.576 127.348 3.634
202306 3.111 128.729 3.128
202309 2.745 129.860 2.736
202312 2.450 129.419 2.450

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioRestorative Therapies  (NAS:BRTX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioRestorative Therapies Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of BioRestorative Therapies's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioRestorative Therapies (BioRestorative Therapies) Business Description

Traded in Other Exchanges
Address
40 Marcus Drive, Suite One, Melville, NY, USA, 11747
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
Executives
Dale Broadrick 10 percent owner 3003 BRICK CHURCH PIKE, NASHVILLE TN 37207
Lance Alstodt director, 10 percent owner, officer: President, CEO, COB BIORESTORATIVE THERAPIES, INC., 40 MARCUS DRIVE, SUITE 1, MELVILLE NY 11747
Francisco Silva director, 10 percent owner, officer: VP of Research and Development STEM CELL ASSURANCE, INC., 555 HERITAGE DRIVE, JUPITER FL 33458
Robert Eugene Kristal officer: Chief Financial Officer 4719 COLE AVENUE, DALLAS TX 75205
Patrick F. Williams director C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
David A Rosa director 10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343
Nickolay V. Kukekov director 4524 WESTWAY AVE, DALLAS TX 75205
Mark Weinreb director, 10 percent owner, officer: CEO and Chairman of the Board STEM CELL ASSURANCE, INC., 555 HERITAGE DRIVE, JUPITER FL 33458
Paul Jude Tonna director 69 CHICHESTER ROAD, HUNTINGTON NY 11743
A. Jeffrey Radov director 8 WALWORTH AVENUE, SCARSDALE NY 10583
Robert Paccasassi officer: VP, Quality and Compliance C/O BIORESTORATIVE THERAPIES, INC., 40 MARCUS DRIVE, SUITE 1, MELVILLE NY 11747
Robert B Catell director 62 OSBORNE ROAD, GARDEN CITY NY 11530
Adam D. Bergstein officer: SVP, Planning and Business Dev 167 HAZEL AVENUE, GLENCOE IL 60022
John M Desmarais director 230 PARK AVENUE, NEW YORK NY 10169
Westbury Trust 10 percent owner VICTORIA HALL, 11 VICTORIA STREET, P.O. BOX HM 1065, HAMILTON D0 00000

BioRestorative Therapies (BioRestorative Therapies) Headlines

From GuruFocus